Abstract

Fibrinolytic enzymes have wide applications in clinical and waste treatment. Bacterial isolates were screened for fibrinolytic enzyme producing ability by skimmed milk agar plate using bromocresol green dye, fibrin plate method, zymography analysis, and goat blood clot lysis. After these sequential screenings, Bacillus sp. IND12 was selected for fibrinolytic enzyme production. Bacillus sp. IND12 effectively used cow dung for its growth and enzyme production (687 ± 6.5 U/g substrate). Further, the optimum bioprocess parameters were found out for maximum fibrinolytic enzyme production using cow dung as a low cost substrate under solid-state fermentation. Two-level full-factorial experiments revealed that moisture, pH, sucrose, peptone, and MgSO4 were the vital parameters with statistical significance (p < 0.001). Three factors (moisture, sucrose, and MgSO4) were further studied through experiments of central composite rotational design and response surface methodology. Enzyme production of optimized medium showed 4143 ± 12.31 U/g material, which was more than fourfold the initial enzyme production (978 ± 36.4 U/g). The analysis of variance showed that the developed response surface model was highly significant (p < 0.001). The fibrinolytic enzyme digested goat blood clot (100%), chicken skin (83 ± 3.6%), egg white (100%), and bovine serum albumin (29 ± 4.9%).

Highlights

  • Fibrinolytic enzymes are used as thrombolytic agents to treat cardiovascular diseases and stroke

  • The Bacillus sp. such as B. subtilis 168, B. subtilis CH3–5, B. amyloliquefaciens CH51, B. amyloliquefaciens CH86, and B. licheniformis CH3–17 produced more than one fibrinolytic enzyme at this range [45]

  • Most of the bacterial fibrinolytic enzymes dissolved blood clot completely (Table 1). These results suggested that fibrinolytic enzymes had obvious effect on dissolving blood clot

Read more

Summary

Introduction

Fibrinolytic enzymes are used as thrombolytic agents to treat cardiovascular diseases and stroke. The search for the effective and safe thrombolytic agent from different biosources keeps growing worldwide. Study reports are available on fibrinolytic enzymes from various organisms, including Bacillus polymyxa [2], Escherichia coli [3], Pseudomonas [4], Streptomyces [5], Paenibacillus sp. Fibrinolytic enzymes have the ability to inhibit blood coagulation and are able to degrade the fibrin [8]. These enzymes have been reported to be produced in BioMed Research International both solid-state fermentation (SSF) and submerged fermentation processes

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call